Dishman Pharma reports 10-fold increase in Q3 consolidated net

10 Feb 2012 Evaluate

Dishman Pharmaceuticals and Chemicals has reported about 10-fold increase in its consolidated net profit at Rs 16.72 crore for the quarter ended December 31. The company had posted a net profit of Rs 1.68 crore in the corresponding period last financial year.

The consolidated total income during the quarter under review also went up by 11.89% to Rs 266.19 crore from Rs 237.89 crore in the year-ago period.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×